Strike action between Monday 2 October to Thursday 5 October 2023

Consultants and junior doctors at The Christie will both strike between 7am on Monday 2 October to 7am on Thursday 5 October 2023. Both consultants and junior doctors will still provide emergency care during their strikes.

We are proactively contacting patients with appointments that may be affected by this strike. If you have an appointment at the Trust on any of these dates, please continue to come to The Christie and our other centres as planned unless we contact you to tell you otherwise. There may be longer waits than usual in clinics during this time.

Please do not call to check if your appointment is still going ahead.

Skip to Content

CAR-T (Chimeric Antigen Receptors Cell Therapy)

Immune cells, called T-cells, are taken from a sample of the patient’s blood. They are then reprogrammed in the lab to recognise and destroy the patient’s cancer cells. This ’living therapy’ is then given to the patient.

In 2019, The Christie joined a group of 9 NHS hospitals approved to provide Chimeric Antigen Receptors Cell Therapy (CAR-T) for adults with large B-cell lymphoma and acute lymphoblastic leukaemia for children and young people up to the age of 25.

The Christie is pleased to announce this product as a standard of care and also for clinical trials. We have been treating patients with these cells since April 2019. 

If you have any queries about our CAR-T therapy services, please email:

Last updated: March 2023